Gwachun-si, South Korea

Junyeong Jin

USPTO Granted Patents = 6 


Average Co-Inventor Count = 6.3

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2021)
  • Gwachun-si, KR (2022 - 2024)
  • Gwacheon-si, KR (2024)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: **Innovative Contributions of Inventor Junyeong Jin**

Introduction

Junyeong Jin is a prominent inventor based in Gwachun-si, South Korea, known for his significant contributions to the fields of biotechnology and medical research. With a total of 6 patents to his name, Junyeong has focused on developing novel therapeutic approaches that target critical health issues.

Latest Patents

Among his latest patents is the innovative "Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof." This patent presents antibodies that specifically bind to human FAM19A5, providing valuable compositions aimed at modulating FAM19A5 activity. Specifically, these antibodies have the potential to inhibit or reverse the onset of reactive gliosis and excessive proliferation of reactive astrocytes, offering promising methods to treat disorders such as central nervous system damage, degenerative brain disorders, and neuropathic pain. Additionally, Junyeong holds a patent for the "Anti-ROS1 antibody and use thereof," which focuses on enhancing the specificity of an anti-ROS1 antibody for cancer diagnosis, marking a vital advancement in the field of oncology.

Career Highlights

Junyeong Jin's career has been marked by his key roles in organizations such as Neuracle Science Co., Ltd. and Seoul National University. His work in these institutions has greatly influenced his research direction and led to the development of multiple cutting-edge patents.

Collaborations

Throughout his career, Junyeong has collaborated with esteemed colleagues, including Junho Chung and Bongcheol Kim. These partnerships have fostered a collaborative environment that has been essential for the innovative research resulting in his patents.

Conclusion

Junyeong Jin continues to be a vital figure in the innovation landscape, consistently pushing the boundaries of medical research and technology. His patents not only reflect a commitment to improving health outcomes but also highlight the importance of collaboration in advancing scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…